About Me

I am focused on identifying strategies for prevention, surveillance, and medical management as it relates to cardiotoxicity in cancer patients as well as health disparities in African Americans with breast cancer. I earned a Master of Science in the Clinical and Population Translational Science (CPTS) program as a T32 Fellow

Highlighted Research Publications

Prasad P, Branch M, Asemota D, Elsayed R, Addison D, Brown S, Cardio-Oncology Preventive Care: Racial and Ethnic Disparities. Curr Cardiovasc Risk Rep. 2020 14 (18) doi.org/10.1007/s12170-020-00650-8

Park C, Branch M, Melendez G, The Role of Cardiac MRI in Animal Models of Cardiotoxicity: Hopes and Challenges, JTCR 2020.

Branch et al. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial. J of Diabetes Complications, 2019.

Abstract |ACC March 2019:  Branch et al. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial. J of Diabetes Complications, 2019

Abstract|ACC March 2020: Racial Differences in Incidence of Cardiotoxicity in Breast Cancer Patients: A Real World Study (1st author)

Abstract |AHA 2020 (in review) :  Association between Breast Cancer and Cardiac Autonomic Function as Measured by Heart Rate Variability in the Women' Health Initiative (1st author)

Abstract| AHA 2020 (in review) : Assessing a Clinical Risk Score and the Impact of Race in Breast Cancer Patients at Risk of Cardiotoxicity (2nd author)